Drug intelligence / Profile preview

D759 + D745 + D029 + D150

Development stage: Unknown
Lead developer: Chong Kun Dang Pharmaceutical
Administration: Intramuscular, Intrathoracic, Epidural, Intravesical

Overview

A **combination drug product** under investigation as part of pharmacokinetic and safety comparison studies. This combination comprises four investigational or code name compounds: D759, D745, D029, and D150. While some individual component code names (e.g., D150) may coincide with established pharmaceuticals, in the context of this combination, the individual substances correspond to specific trial codes, not to any definitively identified generic or brand-name active ingredients. The combination is being assessed in healthy volunteers and in patients with Type 2 Diabetes for safety and efficacy, often as a comparator to another investigational agent (CKD-379)[1][3].

Other names: D759 + D745 + D029 + D150

Beyond the preview

Go deeper on D759 + D745 + D029 + D150.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D759 + D745 + D029 + D150.

Explore the full profile